Intraday Price Movements and Volatility
On the trading day, TTK Healthcare opened with a gap down of 2.16%, reflecting immediate pressure from the market. Despite this, the stock recorded an intraday high of Rs 1148.20, representing a 7.4% rise from the low point, before settling near its lowest levels. The weighted average price volatility for the day stood at 7.36%, indicating heightened fluctuations compared to typical trading sessions.
Notably, the stock has been trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This positioning suggests a prevailing downward trend over multiple time horizons, which has contributed to the current price levels.
Comparative Market Context
While TTK Healthcare’s shares have experienced this decline, the broader market has shown mixed signals. The Nifty index closed at 25,839.65, down by 0.47% or 120.9 points. The index remains close to its 52-week high of 26,325.80, with a margin of 1.88%. Small-cap stocks led gains in the market, with the Nifty Small Cap 100 index rising by 1.14%, contrasting with the performance of TTK Healthcare.
In comparison, the Sensex has recorded a positive return of 3.87% over the past year, while TTK Healthcare’s stock has declined by 28.79% during the same period. This divergence highlights the stock’s relative underperformance within the broader market environment.
Strong fundamentals, solid momentum, fair price – This Large Cap from the NBFC sector checks every box for our Top 1%. This should definitely be on your radar!
- - Complete fundamentals package
- - Technical momentum confirmed
- - Reasonable valuation entry
Financial Performance Overview
Over the last five years, TTK Healthcare’s net sales have shown a compound annual growth rate of 7.36%, indicating modest expansion in revenue. However, recent quarterly results reveal a decline in profit before tax (PBT) excluding other income, which stood at Rs 2.29 crore, reflecting a reduction of 58.29% compared to the previous period.
Non-operating income constitutes a significant portion of the company’s profit before tax, accounting for 89.25% in the latest quarter. This reliance on non-core income sources may influence the overall earnings quality and investor perception.
Shareholding and Market Capitalisation
Despite the company’s size, domestic mutual funds hold a minimal stake of just 0.01%. This limited participation from institutional investors capable of conducting detailed research may reflect a cautious stance towards the stock’s current valuation or business prospects.
TTK Healthcare’s market capitalisation grade is rated at 3, indicating a mid-tier market cap within its sector. The stock’s day change was recorded at 1.31%, outperforming its sector by 1.46% on the day of the recent price low.
Valuation and Profitability Metrics
The company maintains a low average debt-to-equity ratio of zero, suggesting a conservative capital structure with limited leverage. Return on equity (ROE) stands at 6.5%, which, while positive, is moderate relative to industry standards.
TTK Healthcare’s price-to-book value ratio is 1.4, indicating that the stock is trading at a premium compared to its book value. This valuation is higher than the average historical valuations of its peers, reflecting market expectations or sector-specific factors.
Over the past year, the company’s profits have risen by 9.3%, despite the stock’s negative return of 28.79%. The price/earnings to growth (PEG) ratio is 2.3, which provides a measure of valuation relative to earnings growth.
TTK Healthcare . or something better? Our SwitchER feature analyzes this small-cap Diversified stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Long-Term and Recent Performance Trends
TTK Healthcare’s stock has underperformed not only over the past year but also relative to the BSE500 index over the last three years, one year, and three months. This consistent underperformance highlights challenges in maintaining competitive returns within the diversified sector.
The 52-week high for the stock was Rs 1594.95, which contrasts sharply with the recent low of Rs 1046.05, marking a significant decline in valuation over the period.
Summary of Current Market Position
In summary, TTK Healthcare’s recent fall to its 52-week low reflects a combination of subdued revenue growth, earnings pressures excluding other income, and a cautious market stance. The stock’s trading below all major moving averages and its relative underperformance compared to broader indices underscore the challenges faced in the current market environment.
While the company maintains a conservative debt profile and has shown profit growth over the past year, the premium valuation relative to book value and the limited institutional holding suggest a complex investment landscape for this diversified sector stock.
Get 1 year of Weekly Picks FREE when you subscribe to MojoOne. Offer ends soon. Start Saving Now →
